Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection ...Middle East

SHANGHAI, March 28, 2025 /PRNewswire/ -- Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Current Good Manufacturing Practices) on-site inspection by the U.S. Food and Drug...

Read More Details
Finally We wish PressBee provided you with enough information of ( Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection )

Also on site :

• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Monday, June 9
• Israel Detains Greta Thunberg, Other Activists After Halting Gaza-Bound Aid Ship
• Israel blocks Greta Thunberg’s ship from reaching Gaza, group says